Schizophrenia Research
Volume 136, Issue 1 , Pages 25-31 , April 2012

Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia

  • Daniel C. Javitt

      Affiliations

    • Nathan Kline Institute for Psychiatry Research, Orangeburg, NY, United States
    • Corresponding Author InformationCorresponding author at: Nathan Kline Institute, 140 Old Orangeburg Rd, Orangeburg, NY 10962, United States. Tel.: +1 845 398 6534; fax: +1 845 309 6545.
    • ,
  • Robert W. Buchanan

      Affiliations

    • Maryland Psychiatric Research Center, Cantonsville, MD, United States
    • ,
  • Richard S.E. Keefe

      Affiliations

    • Duke University Medical Center, Durham, NC, United States
    • ,
  • Robert Kern

      Affiliations

    • University of California, Los Angeles, Los Angeles, CA, United States
    • ,
  • Robert P. McMahon

      Affiliations

    • Maryland Psychiatric Research Center, Cantonsville, MD, United States
    • ,
  • Michael F. Green

      Affiliations

    • University of California, Los Angeles, Los Angeles, CA, United States
    • ,
  • Jeffrey Lieberman

      Affiliations

    • Columbia University Medical Center, New York, NY, United States
    • ,
  • Donald C. Goff

      Affiliations

    • Massachusetts General Hospital/Harvard Medical School, Boston, MA, United States
    • ,
  • John G. Csernansky

      Affiliations

    • Washington University, St. Louis, MO, United States
    • ,
  • Joseph P. McEvoy

      Affiliations

    • Duke University Medical Center, Durham, NC, United States
    • ,
  • Fred Jarskog

      Affiliations

    • Columbia University Medical Center, New York, NY, United States
    • ,
  • Larry J. Seidman

      Affiliations

    • Massachusetts General Hospital/Harvard Medical School, Boston, MA, United States
    • ,
  • James M. Gold

      Affiliations

    • Maryland Psychiatric Research Center, Cantonsville, MD, United States
    • ,
  • David Kimhy

      Affiliations

    • Columbia University Medical Center, New York, NY, United States
    • ,
  • Karen S. Nolan

      Affiliations

    • Nathan Kline Institute for Psychiatry Research, Orangeburg, NY, United States
    • ,
  • Deanna S. Barch

      Affiliations

    • Washington University, St. Louis, MO, United States
    • ,
  • M. Patricia Ball

      Affiliations

    • Maryland Psychiatric Research Center, Cantonsville, MD, United States
    • ,
  • James Robinson

      Affiliations

    • Nathan Kline Institute for Psychiatry Research, Orangeburg, NY, United States
    • ,
  • Stephen R. Marder

      Affiliations

    • University of California, Los Angeles, Los Angeles, CA, United States

Received 15 August 2011 ,Revised 31 October 2011 ,Accepted 3 November 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Presented at the 2009 meeting of the American College of Neuropsychopharmacology, Hollywood, Florida, Dec. 6–10, 2009.

PII: S0920-9964(11)00564-0

doi: 10.1016/j.schres.2011.11.001

Schizophrenia Research
Volume 136, Issue 1 , Pages 25-31 , April 2012

Article Tools

* Image Usage & Resolution